moving car-t therapy to earlier lines in multiple myeloma and clinical trials in this space
Published 1 year ago • 153 plays • Length 1:06Download video MP4
Download video MP3
Similar videos
-
2:03
car-t therapy in myeloma: moving into earlier lines and treating patients with unmet medical needs
-
2:48
an overview of the current landscape of car t-cell therapy in myeloma
-
1:24
selecting bridging therapy for patients with myeloma prior to car t-cell therapy
-
2:57
strategies to optimize car-t therapy in myeloma: bringing car-t into earlier lines
-
3:23
bringing car-t therapy in earlier lines of treatment in myeloma: karmma-3, cartitude-4 & cartitude-6
-
0:54
ucartcs1: a novel allogeneic car-t therapy for myeloma
-
2:18
moving forward: bringing car-t therapy to a frontline setting in myeloma
-
3:03
the future of car-t therapy for multiple myeloma
-
2:01
car-t updates in myeloma
-
1:22
the potential use of car-t therapy following autologous transplantation in multiple myeloma
-
1:12
optimizing car-t therapy for patients with multiple myeloma in the real-world
-
2:00
the value of car-t cell therapy for the treatment of r/r multiple myeloma
-
2:23
improving car t-cell therapy for myeloma
-
3:06
management of multiple myeloma during car-t therapy manufacturing
-
1:38
real world use of car t-cell therapy in multiple myeloma
-
1:45
car t-cells in myeloma: patients’ perspective
-
2:35
latest advances in car-t for multiple myeloma: cilta-cel & new car-t platforms
-
2:37
moving forwards with car t-cells in myeloma
-
3:27
car-t cells in myeloma